Related Experiment Video
Updated: Jun 9, 2026
10:52
Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
Published on: December 17, 2010
Azathioprine as an alternative treatment in primary hypophysitis
L Papanastasiou1, T Pappa, V Tsiavos
1Department of Endocrinology and Diabetes Center, Athens General Hospital G. Gennimatas, Athens, Attika, Greece. linapapan@yahoo.gr
Pituitary
|September 3, 2010
Summary
Primary hypophysitis (PH) is a rare pituitary disorder. Azathioprine offers a safe and effective alternative treatment for patients unresponsive to or experiencing side effects from glucocorticoids.
Area of Science:
- Endocrinology
- Immunology
- Pharmacology
Background:
- Primary hypophysitis (PH) is a rare inflammatory pituitary gland disorder.
- Glucocorticoids are the standard initial treatment for PH.
- Alternative therapies are needed for glucocorticoid-intolerant or non-responsive patients.
Observation:
- This study presents two cases of PH successfully treated with azathioprine.
- Patients experienced severe side effects from initial glucocorticoid therapy.
- Azathioprine was administered as an alternative treatment option.
Findings:
- Azathioprine demonstrated efficacy in treating primary hypophysitis in these cases.
- The immunosuppressant was well-tolerated, with no significant adverse events reported.
- Successful outcomes suggest azathioprine as a viable alternative therapy.
Implications:
- Azathioprine may be a valuable therapeutic option for refractory or intolerant PH cases.
- Further research is warranted to establish azathioprine's role in PH management.
- This finding could expand treatment strategies for rare pituitary inflammatory diseases.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.